The United States of America; as represented by the Secretary; Department of Health and Human Services
发明人:
Irving William Wainer,Michel Bernier,Rajib Kumar Paul
申请号:
US15225643
公开号:
US10130593B2
申请日:
2016.08.01
申请国别(地区):
US
年份:
2018
代理人:
摘要:
This disclosure concerns the discovery of the use of fenoterol analogs for regulating cannabinoid (CB) receptor activity-related disorders and disease, such as dysregulated CB receptors, including treating a disorder or disease, such as a glioblastoma, hepatocellular carcinoma, liver cancer, colon cancer, and/or lung cancer, which is associated with altered cannabinoid receptor activity. In one example, the method includes administering to a subject having or at risk of developing a disorder or disease regulated by CB receptor activity an effective amount of a fenoterol analog to reduce one or more symptoms associated with the disorder or disease regulated by CB receptor activity.